Sema4 Signal® WES/WTS and PanCancer
Sema4 is dedicated to helping every patient access advanced genomic testing
- Sema4 is contracted with all major national payors and is in-network for >200 million lives.
- Our billing specialists will contact a patient’s insurance company to verify eligibility and obtain pre-certification or pre-authorization to ensure to the fullest extent possible, insurance coverage for testing.
- We appeal coverage determinations on behalf of patients if pre-certification or pre-authorization requests are denied.
- We offer patient support to break down barriers to testing. Payment plans, self-pay pricing, and other financial assistance options are available.